應該
65%
不應該
35%
無意見
0%
認同
61%
不認同
33%
無意見
6%
網頁已經閒置了一段時間，為確保不會錯過最新的內容。請重新載入頁面。立即重新載入
篩選條件
| 股號 | 公司名稱 | 上市日期 | 集資額 | 上市價 | 按盤價 | 首日升跌 | 累積升跌 |
| 02530 | 紐曼思 跌穿上市價 | 2025/01/10 | HKD 2.000億 | 0.800 | 0.660 | -0.110 (-13.750%) | -0.140 (-17.500%) |
| 02593 | 草姬集團 跌穿上市價 | 2024/12/19 | HKD 1.250億 | 3.750 | 1.860 | +0.390 (+10.400%) | -1.890 (-50.400%) |
| 02576 | 太美醫療科技 跌穿上市價 | 2024/10/08 | HKD 3.351億 | 13.000 | 4.410 | -3.800 (-29.231%) | -8.590 (-66.077%) |
| 02592 | 撥康視雲－Ｂ 跌穿上市價 | 2025/07/03 | HKD 6.119億 | 10.100 | 5.690 | -3.900 (-38.614%) | -4.410 (-43.663%) |
| 06681 | 腦動極光－Ｂ | 2025/01/08 | HKD 5.832億 | 3.220 | 5.750 | +0.110 (+3.416%) | +2.530 (+78.571%) |
| 02609 | 佰澤醫療 | 2025/06/23 | HKD 5.617億 | 4.220 | 6.590 | +1.780 (+42.180%) | +2.370 (+56.161%) |
| 02508 | 聖貝拉 | 2025/06/26 | HKD 7.220億 | 6.580 | 7.150 | +2.220 (+33.739%) | +0.570 (+8.663%) |
| 02563 | 華昊中天醫藥－Ｂ 跌穿上市價 | 2024/10/31 | HKD 2.334億 | 16.000 | 7.920 | +4.800 (+30.000%) | -8.080 (-50.500%) |
| 02587 | 健康之路 | 2024/12/30 | HKD 1.950億 | 7.800 | 8.350 | +2.860 (+36.667%) | +0.550 (+7.051%) |
| 02566 | 九源基因 跌穿上市價 | 2024/11/28 | HKD 5.639億 | 12.420 | 9.920 | -4.770 (-38.406%) | -2.500 (-20.129%) |
| 02565 | 派格生物醫藥－Ｂ 創52週高 跌穿上市價 | 2025/05/27 | HKD 3.008億 | 15.600 | 15.480 | -4.040 (-25.897%) | -0.120 (-0.769%) |
| 02651 | 大眾口腔 跌穿上市價 | 2025/07/09 | HKD 2.172億 | 20.000 | 17.100 | +0.700 (+3.500%) | -2.900 (-14.500%) |
| 02410 | 同源康醫藥－Ｂ 創1個月高 | 2024/08/20 | HKD 5.793億 | 12.100 | 21.000 | +1.600 (+13.223%) | +8.900 (+73.554%) |
| 02629 | MIRXES-B | 2025/05/23 | HKD 10.862億 | 23.300 | 30.550 | +6.700 (+28.755%) | +7.250 (+31.116%) |
| 02617 | 藥捷安康－Ｂ | 2025/06/23 | HKD 2.009億 | 13.150 | 32.000 | +10.350 (+78.707%) | +18.850 (+143.346%) |
| 03880 | 泰德醫藥 | 2025/06/30 | HKD 5.141億 | 30.600 | 34.000 | +0.200 (+0.654%) | +3.400 (+11.111%) |
| 02561 | 維昇藥業－Ｂ 跌穿上市價 | 2025/03/21 | HKD 7.833億 | 68.800 | 47.700 | 0.000 (0.000%) | -21.100 (-30.669%) |
| 01276 | 恒瑞醫藥 | 2025/05/23 | HKD 98.901億 | 44.050 | 72.950 | +11.100 (+25.199%) | +28.900 (+65.607%) |
| 02506 | 訊飛醫療科技 | 2024/12/30 | HKD 5.825億 | 82.800 | 109.400 | +4.200 (+5.072%) | +26.600 (+32.126%) |
| 09606 | 映恩生物－Ｂ | 2025/04/15 | HKD 16.396億 | 94.600 | 333.600 | +110.400 (+116.702%) | +239.000 (+252.643%) |
更多IPO資訊
備註
報價延遲最少15分鐘，更新：24/07/2025 17:59
首日升跌：首日收市價與上市價之比較。
累積升跌：按盤價與上市價之比較。
股價將因應送股及拆細作出調整。
公司透過介紹上市，首日開市價將當作為上市價。